Antimicrobial prescribing: cefiderocol (ES1)

This evidence review covers the safety and efficacy data for this intravenous siderophore cephalosporin antibiotic. Three RCTs are reviewed, one of which was for use in carbapenem-resistant gram-negative organisms. Evidence limitations and potential place in therapy are covered

Source:

National Institute for Health and Care Excellence